AR, androgen receptor, 367

N. diseases: 854; N. variants: 163
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2145472
Disease: Urothelial Carcinoma
Urothelial Carcinoma
0.090 AlteredExpression disease BEFREE The aim of the present study was to investigate the expression of transcribed ultraconserved region Uc.63+, and to analyze the effects of Uc.63+ on AR expression and CDDP resistance in UC. 30864720 2019
CUI: C2145472
Disease: Urothelial Carcinoma
Urothelial Carcinoma
0.090 Biomarker disease BEFREE Gender-specific differences have led to the androgen receptor (AR) being considered a possible factor in the pathophysiology of urothelial carcinoma of the bladder (UCB), but the exact role remains unclear. 30831560 2019
CUI: C2145472
Disease: Urothelial Carcinoma
Urothelial Carcinoma
0.090 Biomarker disease BEFREE Combination of androgen receptor inhibitor and cisplatin, an effective treatment strategy for urothelial carcinoma of the bladder. 31006613 2019
CUI: C2145472
Disease: Urothelial Carcinoma
Urothelial Carcinoma
0.090 Biomarker disease BEFREE Accordingly, NF-κB inhibition, together with AR inactivation, has the potential of being an effective chemopreventive and/or therapeutic approach for urothelial carcinoma.<i></i>. 29592878 2018
CUI: C2145472
Disease: Urothelial Carcinoma
Urothelial Carcinoma
0.090 AlteredExpression disease BEFREE This study aims to determine the significance of androgen receptor (AR) expression in urothelial carcinoma of the upper urinary tract (UTUC). 27730305 2017
CUI: C2145472
Disease: Urothelial Carcinoma
Urothelial Carcinoma
0.090 AlteredExpression disease BEFREE Down-regulation of the AR has been shown to inhibit UC growth through increased apoptosis, decreased cell proliferation, and decreased cell migration. 26044568 2016
CUI: C2145472
Disease: Urothelial Carcinoma
Urothelial Carcinoma
0.090 Biomarker disease BEFREE Prognostic effects and regulation of activin A, maspin, and the androgen receptor in upper urinary tract urothelial carcinoma. 21617230 2011
CUI: C2145472
Disease: Urothelial Carcinoma
Urothelial Carcinoma
0.090 Biomarker disease BEFREE Using two AR-positive UC cell lines, TCC-SUP and UMUC3, we demonstrate the expression of the coactivators NCOA1, NCOA2, NCOA3, CREBBP, and EP300 in UC cells. small interfering RNA-mediated knockdown of the AR or any of these coactivators markedly impacted cell viability and abrogated androgen-dependent cell proliferation. 18845648 2009
CUI: C2145472
Disease: Urothelial Carcinoma
Urothelial Carcinoma
0.090 GeneticVariation disease BEFREE Androgen receptor gene polymorphism may affect the risk of urothelial carcinoma. 17922225 2008